Exit Completed: company sold its business/assets or its part of the business to a local partner and leaved the market or liquidated local entity(ies)
Exited Exit CompletedOrion Corporation (Orion Pharma), founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets.
Exit Completed: company sold its business/assets or its part of the business to a local partner and leaved the market or liquidated local entity(ies)
Exited Exit CompletedStop exports to Russia. Finnish Orion Pharma has started the liquidation of its Russian office - it is planned to be closed by the end of 2022. Divested the rights of some of its self-care brands in Russia. Finnish drug manufacturer Orion Pharma is suffering critical losses after leaving the Russian market. The exit itself was not complete because there were no changes in the ownership structure. Also, according to preliminary data, the company's management expects to return to the Russian market in the near future. 19.07.2025: Aleksandr Mayevich Prilepin is no longer the organization's CEO. Anastasia Artemovna Katanisi has become the liquidator of ORION PHARMA.